Skip to main content
Log in

ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006

  • Abstracts
  • Published:
Drug Safety Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Rocca P, El Jastimi S, Troncy J, et al. Imatinib mesylate induced acute cytolytic hepatitis. Gastroenterol Clin Biol 2004; 28: 918–9

    Article  PubMed  Google Scholar 

  2. Ayoub WA, Geller SA, Tran T, et al. Imatinib (Gleevec®)-induced Hepatotoxicity. J Clin Gastroenterol 2005; 39: 75–7

    PubMed  CAS  Google Scholar 

  3. James C, Trouette H, Marit G, et al. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 2003; 17: 978–9

    Article  PubMed  CAS  Google Scholar 

  4. Kikuchi S, Muroi K, Takahashi S, et al. Severe Hepatitis and complete molecular response caused by imatinib mesylate: possible association of its serum concentration with clinical outcomes. Leukemia & Lymphoma 2004 Nov; 45: 2349–51

    Article  Google Scholar 

  5. Danan G. Drug-induced acute hepatic injury. What is the value of diagnostic scales? Gastroenterol Clin Biol 2003; 27Suppl.: B21–5

    PubMed  Google Scholar 

  6. Ganne-carrié N, Leusse A, Guettier C, et al. Autoimmune hepatitis induced by fibrates. Gastroenterol Clin Biol 1998 May; 22(5): 525–9

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nowak, C., Adehossi, A. & Manela, F. ABSTRACTS: ISoP Annual Conference ‘Joining Forces for Managing Risks’ Liège, Belgium 11–13 October, 2006. Drug-Safety 29, 937 (2006). https://doi.org/10.2165/00002018-200629100-00034

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200629100-00034

Keywords

Navigation